EOSE
Eos Energy Enterprises, Inc.
There isn't enough reported data to score EOSE yet.
SVRN
OceanPal Inc. Common Stock
There isn't enough reported data to score SVRN yet.
EOSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
EOSE's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
SVRN Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
SVRN's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
EOSE PE Valuation
EOSE has no meaningful PE right now: it lost money over the past year.
SVRN PE Valuation
SVRN has no meaningful PE right now: it lost money over the past year.
EOSE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect EOSE's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
SVRN Forward outlook
There aren't enough analyst estimates for SVRN to show an outlook.
EOSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$2.69 | +$0.85 |
| Q2 2023 | -$3.76 | -$1.00 |
| Q1 2023 | -$3.65 | -$0.86 |
| Q4 2022 | -$3.68 | -$1.32 |
| Q3 2022 | -$3.54 | +$5.19 |
EOSE is still losing money, but less than at its worst: $4.55 per share over the past year, against $8.73 at its worst in late 2021.
SVRN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2022 | -$8,600.00 | -956% |
SVRN and EOSE do not have enough comparable growth data to identify a winner.
EOSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $82.7M | +171% |
| Q2 2026 | $68.8M | +351% |
| Q1 2026 | $57M | +445% |
| Q4 2025 | $58M | +700% |
| Q3 2025 | $30.5M | +3473% |
| Q2 2025 | $15.2M | +1597% |
| Q1 2025 | $10.5M | +58% |
| Q4 2024 | $7.3M | +9.7% |
EOSE has the edge over SVRN in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -96% | +105 points |
| Q2 2026 | -122% | +297 points |
| Q1 2026 | -139% | +367 points |
| Q4 2025 | -140% | +573 points |
| Q3 2025 | -201% | +6044 points |
| Q2 2025 | -419% | +2815 points |
| Q1 2025 | -506% | +117 points |
| Q4 2024 | -713% | -74 points |
EOSE's operating margin was โ96% last quarter, up 105 points from the same quarter a year ago, near the top of its range since 2019.
SVRN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2022 | $10.8M | +713% |
| Q1 2021 | $3M | +26% |
EOSE has the edge over SVRN in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2025 | -173% | N/A |
| Q4 2022 | -13% | N/A |
| Q2 2022 | 13% | +38 points |
| Q4 2021 | 10% | +31 points |
| Q1 2021 | 7.2% | N/A |
| Q2 2020 | -25% | N/A |
| Q1 2020 | -21% | N/A |
SVRN's operating margin was โ173% last quarter, down 180 points from the same quarter a year ago, near the bottom of its range since 2020.
EOSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$105.1M | -$22.4M |
| Q2 2026 | -$107.4M | -$34.3M |
| Q1 2026 | -$154.8M | -$121M |
| Q4 2025 | -$75.2M | -$19.5M |
| Q3 2025 | -$82.7M | -$28.5M |
| Q2 2025 | -$73.2M | -$40.6M |
| Q1 2025 | -$33.8M | +$10.7M |
| Q4 2024 | -$55.8M | -$10.2M |
EOSE has burned cash in almost every quarter: โ$443M over the past year, against โ$246M the year before.
SVRN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | -$19.1M | -$19.1M |
| Q2 2024 | -$3.3M | +$244K |
| Q1 2021 | $1.7M | +$2.3M |
SVRN and EOSE do not have enough comparable growth data to identify a winner.
EOSE Net Leverage
EOSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SVRN Net Leverage
SVRN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
EOSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 7.4 | Oversold |
EOSE's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
SVRN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.8 | Neutral |
| Stochastic | 19.9 | Oversold |
SVRN's weekly RSI is 45 (neutral) and its Stochastic is 20 (oversold).
EOSE PE vs Industrials Sector
EOSE has no meaningful PE right now: it lost money over the past year.
SVRN PE vs Industrials Sector
| Metric | SVRN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | โ |
SVRN has no meaningful PE right now: it lost money over the past year.
EOSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.24 | 19% below |
| 20 week MA | $3.28 | 45% below |
| 50 week MA | $7.01 | 74% below |
| 100 week MA | $7.10 | 75% below |
| 200 week MA | $4.53 | 60% below |
EOSE is in a downtrend: it's below all five of its weekly moving averages, and 60% below its 200-week average.
SVRN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $32.1 | 53% below |
| 20 week MA | $18.3 | 17% below |
| 50 week MA | $15.4 | 0.8% below |
| 100 week MA | $181.0 | 92% below |
| 200 week MA | $960.3 | 98% below |
SVRN is in a downtrend: it's below all five of its weekly moving averages, and 98% below its 200-week average.
EOSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.72 | $19.2 | +98% |
| 2021 | $19.2 | $8.57 | -55% |
| 2022 | $8.57 | $1.08 | -87% |
| 2023 | $1.08 | $1.09 | +0.9% |
| 2024 | $1.09 | $5.17 | +374% |
| 2025 | $5.17 | $11.9 | +129% |
| 2026 YTD | $11.9 | $1.81 | -85% |
EOSE's yearly returns have swung widely, from +374% in 2024 to โ87% in 2022. It's down 85% so far in 2026.
SVRN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $410,000.0 | $228,000.0 | -44% |
| 2022 | $228,000.0 | $13,500.0 | -94% |
| 2023 | $13,500.0 | $1,115.0 | -92% |
| 2024 | $1,115.0 | $595.0 | -47% |
| 2025 | $595.0 | $20.4 | -97% |
| 2026 YTD | $20.4 | $15.2 | -25% |
SVRN has the edge over EOSE on returns for 2026, with the stronger performance.